drugset
drugset / Trial / NCT02594033

A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

NCT02594033 ↗

Phase 1 Completed 46 enrolled Novo Nordisk A/S
RandomizedCrossoverSingle-blindOther

Summary

This trial is conducted in Europe. The aim of the trial is to investigate different needle features assessed by comparing insulin aspart Pharmacokinetics profiles (the exposure of the trial drug in the body)

Timeline

Start
2015-10-27
Primary completion
2016-01-28
Completion
2016-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic — Other

Indications

diabetes mellitus